PT Kimia Farma Tbk - Company Profile

Powered by

All the sales intelligence you need on PT Kimia Farma Tbk in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how PT Kimia Farma Tbk fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with PT Kimia Farma Tbk.

Back to companies

PT Kimia Farma Tbk: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

PT Kimia Farma Tbk Clinical Trials

Determine PT Kimia Farma Tbk go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of PT Kimia Farma Tbk Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 6 results.
Deserunt mollit sunt Lorem GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Pfizer Inc
Safety & Immunogenicity of Booster SARA-COV-2 Vaccine (Vero Cell) GDCT0443884 Coronavirus Disease 2019 (COVID-19) vaccine 2 Infectious Disease Coronavirus Disease 2019 (COVID-19) Phase II Ongoing, recruiting PT Kimia Farma Tbk
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine GDCT0439827 BBIBP-CorV Infectious Disease Coronavirus Disease 2019 (COVID-19) Phase IV Ongoing, not recruiting PT Kimia Farma Tbk
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject GDCT0428875 acyclovir Dermatology; Infectious Disease; Ophthalmology Chicken Pox; Cytomegalovirus (HHV-5) Infections; Fever Blisters; Genital Herpes; Herpes Labialis (Oral Herpes); Herpes Simplex Encephalitis; Herpes Zoster (Shingles); Herpesviridae Infections; Herpetic Keratitis; Simplexvirus (HSV) Infections; Varicella Zoster (HHV-3) Infections; Viral Keratitis Phase I Completed PT Kimia Farma Tbk
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Gain a 360-degree view of PT Kimia Farma Tbk and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer